
Commentary|Podcasts|July 14, 2023
Pharmacy Focus: Psychedelic Pharmacy - Digital Therapeutics in Psychedelic Medicine
David Keene, vice president of Digital Therapeutics at atai Life Sciences, discussed the growth and future of digital therapeutics.
Advertisement
This month, we sat down with David Keene, vice president of Digital Therapeutics at atai Life Sciences, to discuss the growth and future of digital therapeutics.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Nufymco, Interchangeable Ranibizumab Biosimilar, for Retinal Diseases
2
Achieving Optimal LDL-C Helps Prevent Neoatherosclerosis, Late Stent Failure in Patients With STEMI
3
FDA Approves First Oral GLP-1 for Weight Management
4
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
5







































































































































































































